GMC to reopen study on stroke

LAWRENCEVILLE — Gwinnett Medical Center will reopen an acute stroke clinical research study, delving into the potential for treatment over a longer period of time.

Atlanta-based Dr. Marshall L. Nash, the director of stroke and neuroscience research at GMC and CEO of neurostudies.net, is a leading enroller of patients in clinical research studies investigating potential treatment options of stroke where there are no alternatives available.

The only FDA-approved treatment for acute stroke must be given within a few hours after the onset of stroke symptoms.

The study will explore the possibility of effective treatment for up to 24 hours after the onset of symptoms.

“A large part of my clinical research practice at neurostudies.net and Gwinnett Medical Center is conducting cutting edge research for diseases with no viable treatment option,” Nash said.

For more information, visit neurostudies.net.